An Extraordinary Gift Forges an International Partnership

Increasing access to clinical trials worldwide

Clinical trials are the critical step in translating scientific discoveries into lifesaving treatments, yet fewer than 5% of people with cancer around the world are enrolled in one. Trials are often centralized in major cities, putting them out of reach for people in remote and underserved areas, and a lack of international collaboration is a well-recognized barrier to ensuring diverse enrollment. Memorial Sloan Kettering Cancer Center (MSK) is proud to begin tackling both issues thanks to a remarkable $20 million gift made by Australian philanthropists Gregory John Poche and Kay Van Norton Poche.

The family’s generosity has allowed MSK to establish the Gregory John Poche and Kay Van Norton Poche Initiative for Clinical Trials Access in Sydney and the Gregory John Poche and Kay Van Norton Poche Fellowship Fund at MSK.

A first-of-its-kind partnership

Greg and Kay
With generous support from Gregory John Poche, left, and Kay Van Norton Poche, MSK aims to increase access to clinical trials worldwide and speed up investigational drug development.

The initiative creates a framework for collaboration between MSK and the Royal North Shore Hospital and North Shore Private Hospital, both located in Sydney. This first-of-its-kind partnership for MSK aims to build a global model for using telehealth and data sharing to decentralize the clinical trial process and speed the evaluation of investigational drugs.

“Clinical trials and drug development are central to our efforts to fight cancer and heal people,” says Kay Van Norton Poche. “By building a bridge between MSK and Sydney, we are uniting the expertise needed to deliver the best care and advance incredibly important research.”

The Gregory John Poche and Kay Van Norton Poche Fellowship Fund will be a vital addition to MSK’s educational offerings and will serve as an enduring reminder of Mr. and Mrs. Poche’s commitment to cancer care.

Strengthening global collaboration to accelerate cures

Medical oncologist and drug development scientist Bob Li, MD, PhD, MPH, who is the Physician Ambassador to China and Asia-Pacific at MSK’s International Center, will lead MSK’s participation in this partnership. “Gregory and Kay’s generosity and commitment to improving cancer research and care are truly inspirational,” says Dr. Li. “Cancer is a global problem that requires global solutions, and this gift, which will strengthen collaboration between the United States and Australia on clinical trials, is a critical first step toward creating a model that brings other nations together to accelerate new cures for cancer.”

Help fuel a future of new firsts

Every day, MSK brings courage and creativity to answering cancer’s biggest questions, and we have set an ambitious goal to create more hope, possibility, and cures for every person with cancer.
Explore community stories
Discover how members of our community are making an impact
Make a gift
Donate to MSK to fund life-changing research and care
Attend an event
Come to a fundraising event to show your support
Start a fundraiser
Invite your friends and family to join you in your mission